South Korea · Delayed Price · Currency is KRW Genoray Statistics
Total Valuation
Genoray has a market cap or net worth of KRW 57.34 billion. The enterprise value is 73.96 billion.
| Market Cap | 57.34B |
| Enterprise Value | 73.96B |
Important Dates
The last earnings date was Tuesday, February 24, 2026.
| Earnings Date | Feb 24, 2026 |
| Ex-Dividend Date | Mar 30, 2026 |
Share Statistics
Genoray has 12.15 million shares outstanding. The number of shares has decreased by -6.71% in one year.
| Current Share Class | 12.15M |
| Shares Outstanding | 12.15M |
| Shares Change (YoY) | -6.71% |
| Shares Change (QoQ) | +3.36% |
| Owned by Insiders (%) | 32.85% |
| Owned by Institutions (%) | 0.03% |
| Float | 8.06M |
Valuation Ratios
The trailing PE ratio is 77.38.
| PE Ratio | 77.38 |
| Forward PE | n/a |
| PS Ratio | 0.53 |
| PB Ratio | 0.68 |
| P/TBV Ratio | 0.69 |
| P/FCF Ratio | 14.49 |
| P/OCF Ratio | 10.90 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.97, with an EV/FCF ratio of 18.70.
| EV / Earnings | 97.61 |
| EV / Sales | 0.68 |
| EV / EBITDA | 8.97 |
| EV / EBIT | n/a |
| EV / FCF | 18.70 |
Financial Position
The company has a current ratio of 1.94, with a Debt / Equity ratio of 0.41.
| Current Ratio | 1.94 |
| Quick Ratio | 0.75 |
| Debt / Equity | 0.41 |
| Debt / EBITDA | 4.12 |
| Debt / FCF | 8.60 |
| Interest Coverage | -0.22 |
Financial Efficiency
Return on equity (ROE) is 0.74% and return on invested capital (ROIC) is -0.24%.
| Return on Equity (ROE) | 0.74% |
| Return on Assets (ROA) | -0.12% |
| Return on Invested Capital (ROIC) | -0.24% |
| Return on Capital Employed (ROCE) | -0.27% |
| Weighted Average Cost of Capital (WACC) | 4.75% |
| Revenue Per Employee | 300.12M |
| Profits Per Employee | 2.10M |
| Employee Count | 360 |
| Asset Turnover | 0.85 |
| Inventory Turnover | 1.50 |
Taxes
| Income Tax | -1.76B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -10.44% in the last 52 weeks. The beta is 0.32, so Genoray's price volatility has been lower than the market average.
| Beta (5Y) | 0.32 |
| 52-Week Price Change | -10.44% |
| 50-Day Moving Average | 4,362.20 |
| 200-Day Moving Average | 4,803.08 |
| Relative Strength Index (RSI) | 67.40 |
| Average Volume (20 Days) | 85,560 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Genoray had revenue of KRW 108.04 billion and earned 757.69 million in profits. Earnings per share was 61.00.
| Revenue | 108.04B |
| Gross Profit | 41.26B |
| Operating Income | -243.29M |
| Pretax Income | -1.13B |
| Net Income | 757.69M |
| EBITDA | 8.25B |
| EBIT | -243.29M |
| Earnings Per Share (EPS) | 61.00 |
Balance Sheet
The company has 16.64 billion in cash and 34.01 billion in debt, with a net cash position of -17.37 billion or -1,429.54 per share.
| Cash & Cash Equivalents | 16.64B |
| Total Debt | 34.01B |
| Net Cash | -17.37B |
| Net Cash Per Share | -1,429.54 |
| Equity (Book Value) | 83.75B |
| Book Value Per Share | 6,718.11 |
| Working Capital | 37.70B |
Cash Flow
In the last 12 months, operating cash flow was 5.26 billion and capital expenditures -1.30 billion, giving a free cash flow of 3.96 billion.
| Operating Cash Flow | 5.26B |
| Capital Expenditures | -1.30B |
| Depreciation & Amortization | 8.49B |
| Net Borrowing | -256.85M |
| Free Cash Flow | 3.96B |
| FCF Per Share | 325.63 |
Margins
Gross margin is 38.19%, with operating and profit margins of -0.23% and 0.70%.
| Gross Margin | 38.19% |
| Operating Margin | -0.23% |
| Pretax Margin | -1.05% |
| Profit Margin | 0.70% |
| EBITDA Margin | 7.64% |
| EBIT Margin | -0.23% |
| FCF Margin | 3.66% |
Dividends & Yields
This stock pays an annual dividend of 150.00, which amounts to a dividend yield of 3.18%.
| Dividend Per Share | 150.00 |
| Dividend Yield | 3.18% |
| Dividend Growth (YoY) | 11.11% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 296.06% |
| Buyback Yield | 6.71% |
| Shareholder Yield | 9.89% |
| Earnings Yield | 1.32% |
| FCF Yield | 6.90% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on February 21, 2020. It was a forward split with a ratio of 3.
| Last Split Date | Feb 21, 2020 |
| Split Type | Forward |
| Split Ratio | 3 |
Scores
Genoray has an Altman Z-Score of 2.85 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.85 |
| Piotroski F-Score | 4 |